祥生医疗发布2025年度业绩快报，盈利1.166亿元

Group 1 - The core viewpoint of the article indicates that Xiangsheng Medical is set to release its 2025 annual report, with a reported net profit of 116.6 million yuan, reflecting a year-on-year decrease of 16.99% [1] Group 2 - During the reporting period, the company achieved an operating revenue of 447.35 million yuan, a decrease of 4.55% compared to the same period last year [2] - The net profit attributable to the parent company was 116.63 million yuan, down 16.99% year-on-year, while the net profit after deducting non-recurring gains and losses was 103.36 million yuan, a decline of 18.69% [2] - Basic earnings per share were reported at 1.04 yuan, a decrease of 17.46% compared to the previous year [2] - At the end of the reporting period, the company had total assets of 1.598 billion yuan, an increase of 0.11% year-on-year, while the equity attributable to the parent company decreased by 2.59% to 1.384 billion yuan [2] - The decline in net profit was primarily attributed to a decrease in operating revenue and foreign exchange losses due to fluctuations in the US dollar exchange rate [2] Group 3 - Xiangsheng Medical specializes in the research, development, manufacturing, and sales of ultrasound medical imaging equipment, providing various ultrasound medical imaging devices and professional technical development services to domestic and international medical institutions and research organizations [4] - In the last 90 days, three institutions have given buy ratings for the stock [5]